X0202 4 2004-06-02 1 0000719447 HYCOR BIOMEDICAL INC /DE/ HYBD 0001193649 PHELPS JAMES R 7272 CHAPMAN AVENUE GARDEN GROVE CA 92841 1 0 0 0 Common Stock 2004-06-02 4 D 0 36215 D 0 D Nonqualified Stock Option (Right to Buy) 4.63 2004-06-02 4 D 0 6000 D 2004-06-02 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 4.69 2004-06-02 4 D 0 6000 D 2005-06-11 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 4.63 2004-06-02 4 D 0 6000 D 2006-05-29 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 1.94 2004-06-02 4 D 0 6000 D 2007-05-28 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 2.00 2004-06-02 4 D 0 6000 D 2008-06-09 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 1.25 2004-06-02 4 D 0 6000 D 2009-06-09 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 6.13 2004-06-02 4 D 0 6000 D 2010-06-13 Common Stock 6000 0 D Nonqualified Stock Option (Right to Buy) 7.65 2004-06-02 4 D 0 4000 D 2011-06-13 Common Stock 4000 0 D Nonqualified Stock Option (Right to Buy) 3.49 2004-06-02 4 D 0 2000 D 2012-06-12 Common Stock 2000 0 D Nonqualified Stock Option (Right to Buy) 4.26 2004-06-02 4 D 0 0 D 2013-06-09 Common Stock 0 0 D Disposed of pursuant to merger agreement between issuer and Stratagene Corporation in exchange for 22,301shares of Stratagene common stock having a market value of $ per share on the effective date of the merger (based on the closing price of issuer's common stock on the effective date of the merger multiplied by the exchange ratio of 0.6158). This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $7.52 per share. This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $7.62 per share. This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $7.52 per share. This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $3.16 per share. This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $3.25 per share. This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $2.03 per share. This option is fully vested and was assumed by Stratagene in the merger and replaced with an option to purchase 3694 shares of Stratagene common stock for $9.96 per share. This option, which provided for vesting in 3 equal installments beginning 6/14/01, 2000 shares have not vested and will expire. The remaining 4000 shares were assumed by Stratagene in the merger and replaced with an option to purchase 2463 shares of Stratagene common stock for $12.43 per share. This option, which provided for vesting in 3 equal installments beginning 6/13/02, 4000 shares have not vested and will expire. The remaining 2000 shares were assumed by Stratagene in the merger and replaced with an option to purchase 1231 shares of Stratagene common stock for $5.67 per share. This option, which provided for vesting in 3 equal installments beginning 6/10/04, have not vested and will expire. Reg Jones, Attorney-in-Fact, On Behalf of James R. Phelps 2004-06-09